IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 187 filers reported holding IMMUNOGEN INC in Q3 2020. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $37,625,612 | -16.8% | 2,370,864 | -1.1% | 0.01% | -22.2% |
| Q2 2023 | $45,213,388 | +449.2% | 2,396,046 | +11.8% | 0.01% | +350.0% |
| Q1 2023 | $8,232,273 | -22.8% | 2,143,821 | -0.2% | 0.00% | 0.0% |
| Q4 2022 | $10,656,739 | +4.8% | 2,148,536 | +1.0% | 0.00% | 0.0% |
| Q3 2022 | $10,167,000 | +5.4% | 2,126,854 | -0.8% | 0.00% | 0.0% |
| Q2 2022 | $9,648,000 | -7.8% | 2,144,130 | -2.5% | 0.00% | 0.0% |
| Q1 2022 | $10,463,000 | -33.8% | 2,198,238 | +3.2% | 0.00% | -33.3% |
| Q4 2021 | $15,801,000 | +32.2% | 2,129,508 | +1.0% | 0.00% | +50.0% |
| Q3 2021 | $11,954,000 | -14.9% | 2,108,404 | -1.1% | 0.00% | 0.0% |
| Q2 2021 | $14,052,000 | -17.3% | 2,132,366 | +1.7% | 0.00% | -33.3% |
| Q1 2021 | $16,984,000 | +24.3% | 2,096,792 | -1.0% | 0.00% | 0.0% |
| Q4 2020 | $13,663,000 | +84.3% | 2,118,275 | +2.9% | 0.00% | +50.0% |
| Q3 2020 | $7,412,000 | -25.1% | 2,059,025 | -4.3% | 0.00% | 0.0% |
| Q2 2020 | $9,896,000 | +37.0% | 2,151,300 | +1.6% | 0.00% | 0.0% |
| Q1 2020 | $7,221,000 | -21.0% | 2,117,504 | +18.3% | 0.00% | 0.0% |
| Q4 2019 | $9,140,000 | +102.2% | 1,790,481 | -4.1% | 0.00% | +100.0% |
| Q3 2019 | $4,521,000 | +17.8% | 1,867,991 | +5.7% | 0.00% | 0.0% |
| Q2 2019 | $3,837,000 | -20.0% | 1,767,974 | -0.1% | 0.00% | 0.0% |
| Q1 2019 | $4,795,000 | -43.7% | 1,769,126 | -0.3% | 0.00% | -50.0% |
| Q4 2018 | $8,514,000 | -49.9% | 1,773,773 | -1.2% | 0.00% | -50.0% |
| Q3 2018 | $16,998,000 | +9.7% | 1,794,927 | +12.7% | 0.00% | 0.0% |
| Q2 2018 | $15,492,000 | +20.2% | 1,592,167 | +30.0% | 0.00% | +33.3% |
| Q1 2018 | $12,885,000 | +66.2% | 1,224,830 | +1.3% | 0.00% | +50.0% |
| Q4 2017 | $7,751,000 | -4.4% | 1,209,300 | +14.1% | 0.00% | 0.0% |
| Q3 2017 | $8,109,000 | +8.6% | 1,060,119 | +0.9% | 0.00% | 0.0% |
| Q2 2017 | $7,469,000 | +80.6% | 1,050,380 | -1.7% | 0.00% | +100.0% |
| Q1 2017 | $4,136,000 | +99.0% | 1,068,820 | +5.0% | 0.00% | 0.0% |
| Q4 2016 | $2,078,000 | -23.1% | 1,018,244 | +1.0% | 0.00% | 0.0% |
| Q3 2016 | $2,702,000 | -13.2% | 1,008,154 | -0.2% | 0.00% | 0.0% |
| Q2 2016 | $3,112,000 | -64.8% | 1,010,304 | -2.6% | 0.00% | -66.7% |
| Q1 2016 | $8,835,000 | -36.0% | 1,037,003 | +2.0% | 0.00% | -40.0% |
| Q4 2015 | $13,802,000 | +45.2% | 1,017,136 | +2.7% | 0.01% | +66.7% |
| Q3 2015 | $9,506,000 | -33.5% | 990,205 | -0.4% | 0.00% | -25.0% |
| Q2 2015 | $14,297,000 | +64.3% | 994,244 | +2.2% | 0.00% | +33.3% |
| Q1 2015 | $8,704,000 | +47.4% | 972,515 | +0.4% | 0.00% | +50.0% |
| Q4 2014 | $5,906,000 | -44.3% | 968,261 | -3.2% | 0.00% | -33.3% |
| Q3 2014 | $10,598,000 | -10.4% | 1,000,721 | +0.3% | 0.00% | -25.0% |
| Q2 2014 | $11,822,000 | -31.7% | 997,714 | -13.9% | 0.00% | -20.0% |
| Q1 2014 | $17,300,000 | -3.9% | 1,158,722 | -5.5% | 0.01% | -16.7% |
| Q4 2013 | $17,995,000 | -12.1% | 1,226,683 | +2.0% | 0.01% | -14.3% |
| Q3 2013 | $20,476,000 | +1.9% | 1,203,027 | -0.6% | 0.01% | 0.0% |
| Q2 2013 | $20,086,000 | – | 1,210,754 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
| CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
| Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
| RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
| Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
| Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
| Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
| QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
| Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |